Reporting owner · CIK 0001974200

Howe Jolanda

Visual SEC Form 4 history across 1 companies, 19 transactions and 7 filings.

SVP, CTRLSVP, GLOBAL CONTROLLERMirum Pharmaceuticals, Inc.
Open-market mix
Latest filingSep 03, 2026, 10:54 PM
Filings7Form 4 records
Buying$00 purchases
Selling$4.3M6 sales
Net value−$4.3MBuys minus sells
Companies15 securities
Most recentSep 02, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-52Jan 251Feb 25Jan 261Feb 261Aug 261Sep 26

Net value flow

Buys minus sells

Jan 25
−$75.3K
Feb 25
−$51.3K
Jan 26
$0
Feb 26
−$100K
Aug 26
−$4M
Sep 26
−$65.8K

Transaction texture

Ownership and ticket size

Average P/S size$715.4K
Median P/S size$58.6K
Direct19
Indirect0
Sep 02, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern4Derivative Transactionfiling-context8Direct Ownershipfiling-context18Large Holdings Increaseholdings8Large Holdings Reductionholdings6Large Salesize2Repeat Sellerpattern1

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Mirum Pharmaceuticals, Inc. on Sep 02, 2026 valued at $65,800.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Mirum Pharmaceuticals, Inc. on Sep 02, 2026 valued at $65,800.

Review SEC filing

Associated companies

Visual map of known reporting history

MIRMMirum Pharmaceuticals, Inc.19 transactions · latest Sep 03, 2026, 10:54 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
MIRMHowe Jolanda
SVPCTRL
sale10b5-1658-$6.58MS
Cluster Selling Direct Ownership Large Holdings Reduction+2
0.0%09/0309/02
MIRMHowe Jolanda
SVPCTRL
exercise40.0k$0M
Derivative Transaction Direct Ownership
−3.8%08/1908/18
MIRMHowe Jolanda
SVPCTRL
sale40.0k-$400MS
Direct Ownership Large Holdings Reduction Large Sale
−3.8%08/1908/18
MIRMHowe Jolanda
SVPCTRL
exercise40.0k$25.0MM
Direct Ownership Large Holdings Increase
−3.8%08/1908/18
MIRMHowe Jolanda
SVPCTRL
exercise1.77k$0M
Derivative Transaction Direct Ownership
−7.0%02/0401/31
MIRMHowe Jolanda
SVPCTRL
sale968-$9.99MS
Cluster Selling Direct Ownership Large Sale
−7.0%02/0402/02
MIRMHowe Jolanda
SVPCTRL
exercise1.77k—M
Direct Ownership Large Holdings Increase
−7.0%02/0401/31
MIRMHowe Jolanda
SVPCTRL
exercise1.77k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction
—02/04/202501/31/2025
MIRMHowe Jolanda
SVPCTRL
sale1.06k-$5.13MS
Cluster Selling Direct Ownership Large Holdings Reduction+1
—02/04/202502/03/2025
MIRMHowe Jolanda
SVPCTRL
exercise1.77k—M
Direct Ownership Large Holdings Increase
—02/04/202501/31/2025

Howe Jolanda Insider Activity FAQ

SEC Form 4 context

Who is Howe Jolanda?

Howe Jolanda is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001974200.

Which companies has Howe Jolanda reported transactions for?

Mirum Pharmaceuticals, Inc.

When was Howe Jolanda's latest insider buy?

No open-market insider purchase is available for this period.

When was Howe Jolanda's latest insider sale?

sale at Mirum Pharmaceuticals, Inc. on Sep 02, 2026 valued at $65,800.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.